Stock UniverseDerived research view · source repositories remain read-only

Verrica Pharmaceuticals Inc. (VRCA)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
20.38
Global Rank
3318
Market Cap
87.46M
Latest Close
6.04
RS Composite
-24.15% · G#2828

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-28.35%
3M
13.75%
6M
-19.25%
1Y
1.51%
3Y
-89.35%
5Y
-94.64%
10Y
-96.55%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 60.36K · 30-day average: 74.94K · Max drawdown over stored range: -98.39%

Research Snapshot

Relative Strength vs SPX

RS Composite-24.15%
20D RS-27.33%
60D RS-12.49%
120D RS-34.22%
Global RS Rank2828 · 15.71% percentile
Watch+Speculative RS Rank1730 · 17.50% percentile
Group ScopeWatch+Speculative
Primary RS Rank330 · 27.95% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank451 / 701
Primary Percentile35.81
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for VRCA.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0129.0325.1247.56635.577
Revenue Growth (YoY)3100%3100%-24.733%-43.268%47.658%370.222%
Gross Profit0-3.929-3.891-15.917-7.014
Operating Income-40.181-30.908-21.296-63.222-65.036
Free Cash Flow-31.677-28.465-18.952-38.939-60.954-17.627
Free Cash Flow Per Share-12.673-10.525-5.547-8.588-11.765-1.6547495969675097
EPS (Diluted) GAAP-17.080633-13-7.167603-14.775337-14.781242
EPS Growth
EPS Non-GAAP
Gross Margin3100%-32.742%-43.08%3100%-92.704%90.328%
Operating Margin3100%-257.567%-235.784%-1233.841%-859.582%-34.2497%
Profit Margin3100%-292.333%-271.114%-1307.475%-1012.146%-50.2741%
Free Cash Flow Margin3100%-237.208%-209.832%-759.934%-805.63%-49.5461%
Shares Outstanding (Diluted)2.49962.70443.41634.53425.180810.6524
Shares Change (YoY)0.392%8.197%26.323%32.722%14.26%105.612%

SEC Quarterly Fundamentals

No processed quarterly rows for VRCA.